IRIS
LANZILLOTTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.989
AS - Asia 2.144
NA - Nord America 1.779
SA - Sud America 475
AF - Africa 33
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.437
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.685
RU - Federazione Russa 1.473
CN - Cina 754
SG - Singapore 734
IT - Italia 712
BR - Brasile 375
SE - Svezia 249
HK - Hong Kong 243
VN - Vietnam 183
DE - Germania 123
FR - Francia 108
GB - Regno Unito 93
IN - India 59
FI - Finlandia 51
CA - Canada 46
AR - Argentina 39
NL - Olanda 35
PL - Polonia 35
MX - Messico 34
TR - Turchia 31
ES - Italia 27
JP - Giappone 26
AT - Austria 18
IQ - Iraq 18
ZA - Sudafrica 15
CO - Colombia 13
EC - Ecuador 13
ID - Indonesia 13
IE - Irlanda 12
PE - Perù 12
PK - Pakistan 12
BD - Bangladesh 11
PH - Filippine 11
UA - Ucraina 11
AU - Australia 9
IL - Israele 9
UZ - Uzbekistan 9
NZ - Nuova Zelanda 7
VE - Venezuela 7
CL - Cile 6
LT - Lituania 6
MD - Moldavia 6
RO - Romania 6
KE - Kenya 5
MA - Marocco 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
GR - Grecia 4
IR - Iran 4
LV - Lettonia 4
TN - Tunisia 4
BE - Belgio 3
CZ - Repubblica Ceca 3
EG - Egitto 3
JO - Giordania 3
SA - Arabia Saudita 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
GY - Guiana 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
KR - Corea 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
AM - Armenia 1
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
KZ - Kazakistan 1
LK - Sri Lanka 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 7.437
Salva come PNG Salva come JPEG
Città #
Singapore 368
Dallas 299
Moscow 260
Hong Kong 239
Ashburn 223
San Jose 213
Shanghai 162
Beijing 143
Milan 111
New York 96
Hefei 85
Lauterbourg 81
Lawrence 69
Princeton 69
Ho Chi Minh City 64
Los Angeles 61
Rome 57
Hanoi 45
Boardman 40
Helsinki 37
Munich 37
São Paulo 37
Warsaw 30
Orem 28
Santa Clara 28
Nuremberg 26
Denver 24
London 24
Tokyo 22
Montreal 19
Poplar 19
Cagliari 17
Seattle 16
Pune 15
Ankara 14
Frankfurt am Main 14
Bologna 13
Florence 13
Turin 13
Atlanta 12
Brooklyn 12
Chennai 12
Dublin 12
Guangzhou 12
Naples 12
Rio de Janeiro 12
Boston 11
Council Bluffs 11
Mexico City 11
Phoenix 11
Bari 10
Belo Horizonte 10
Rovigo 10
Toronto 10
Amsterdam 9
Bergamo 9
Galliate 9
Pescara 9
Stockholm 9
Baghdad 8
Chicago 8
Houston 8
Johannesburg 8
Mumbai 8
Pietra Ligure 8
Querétaro 8
Secaucus 8
Tashkent 8
Turku 8
Vaprio d'Adda 8
Verona 8
Basingstoke 7
Breda 7
Falkenstein 7
Haiphong 7
Jakarta 7
Madrid 7
Mugnano di Napoli 7
New Delhi 7
Vienna 7
Belluno 6
Brasília 6
Cesano Boscone 6
City of London 6
Jiaxing 6
Monza 6
Perugia 6
Quito 6
Auckland 5
Campo Grande 5
Caxias do Sul 5
Hải Dương 5
Istanbul 5
Kyiv 5
Lappeenranta 5
Mezzolombardo 5
Mira 5
Nairobi 5
Quezon City 5
Salvador 5
Totale 3.611
Salva come PNG Salva come JPEG
Nome #
PACHIMENINGITE IPERTROFICA IGG4-CORRELATA: DIAGNOSI E RISPOSTA TERAPEUTICA 364
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 181
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 168
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 166
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 161
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 151
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 148
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 135
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 126
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 125
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 125
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 120
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 117
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 116
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 115
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 109
Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients 108
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 108
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 107
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 107
Advances in the diagnosis and management of IgG4 related disease. 107
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 104
Association of IgG4-related disease and systemic rheumatic disorders 100
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 100
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 99
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 99
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 98
Urgent manifestations of immunoglobulin G4-related disease 97
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 96
A unique case of IgG4-related pachymeningitis treated with intrathecal rituximab 96
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES 95
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 94
Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort 93
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. 92
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 90
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 88
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 88
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE 87
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 85
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 84
CIRCULATING PLASMABLASTS LEVELS REFLECT INFLAMMATORY ACTIVITY IN IGG4-RELATED DISEASE LESIONS AS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY 79
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 78
CLINICAL PHENOTYPES OF IGG4-RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL, IMMUNOLOGICAL AND PROGNOSTIC FEATURES 78
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 78
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease 77
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index 76
EFFECTS OF GLUCOCORTICOIDS AND METHOTREXATE-BASED THERAPEUTIC REGIMENS ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 75
INFLAMMATORY ACTIVITY OF IgG4-RELATED DISEASE LESIONS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY CORRELATES WITH CIRCULATING PLASMABLASTS LEVELS 75
HLA-DRB1∗16 and -DQB1∗05 alleles are strongly associated with autoimmune pancreatitis in a cohort of hundred patients 73
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 72
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 72
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis 70
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 70
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 69
IgG4-RELATED DISEASE PRESENTATION REQUIRES ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES 68
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 67
MALATTIA IGG4-CORRELATA: ESPERIENZA QUINQUENNALE MONOCENTRICA SU UNA CORTE ITALIANA DI 150 PAZIENTI (2013 - 2018) 67
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis 66
INCREASE OF CIRCULATING MEMORY B CELLS AFTER GLUCOCORTICOID-INDUCED REMISSION PREDICTS IGG4-RELATED DISEASE RELAPSE 66
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse 62
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 62
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circula-ting plasmablasts in IgG4-related type 1 au-toimmune pancreatitis and other organs 61
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 61
Disentangling inflammatory drivers of fibrosis in IgG4-related disease 59
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 58
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 56
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 56
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment 55
Immunology of IgG4-related disease 54
DECONSTRUCTING LA MALATTIA DA IGG4 CON INTERESSAMENTO DELLE STRUTTURE MEDIANE: CONFRONTO CON I COMUNI “MIMICKERS” 53
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease 53
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 52
Methotrexate as induction of remission the-rapy for IgG4-Related type 1 Autoimmune Pancreatitis 51
FENOTIPI CLINICI DELLA MALATTIA IGG4 CORRELATA: ANALISI CROSS-SECTIONAL DI UNA CORTE INTERNAZIONALE 51
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 51
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 50
Roles of Plasmablasts and B Cells in IgG4-Related Disease: Implications for Therapy and Early Treatment Outcomes 50
Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease 49
EFFETTI DELLA TERAPIA CON PREDNISONE E METHOTREXATE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI AFFETTI DA MALATTIA-IgG4 CORRELATA 49
Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply 48
EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE 48
Serum IgG4 level predicts COVID-19 related mortality 47
IGG4-RELATED DISEASE IN ITALY: RESULTS FROM A MONOCENTRIC COHORT OF 150 PATIENTS (2013–2018) 47
Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis 45
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 45
EFFICACIA E SICUREZZA DELLA SOMMINISTRAZIONE INTRATECALE DI RITUXIMAB PER IgG4-RELATED PACHIMENINGITE IPERTROFICA REFRATTARIA 43
Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction Model 18
B-cell depletion with obinutuzumab for the treatment of IgG4-related disease 5
Totale 7.564
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.030
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 2 1
2021/2022156 0 0 46 12 2 10 7 9 21 15 18 16
2022/2023546 170 93 42 6 12 54 53 40 33 5 12 26
2023/2024593 26 39 69 46 38 88 22 69 6 24 61 105
2024/20251.474 139 57 51 50 72 105 243 172 252 89 96 148
2025/20264.761 332 372 361 552 429 191 408 375 1.312 332 97 0
Totale 7.564